all AI news
ACEGEN: Reinforcement learning of generative chemical agents for drug discovery
May 9, 2024, 4:41 a.m. | Albert Bou, Morgan Thomas, Sebastian Dittert, Carles Navarro Ram\'irez, Maciej Majewski, Ye Wang, Shivam Patel, Gary Tresadern, Mazen Ahmad, Vincent M
cs.LG updates on arXiv.org arxiv.org
Abstract: In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capability, flexibility, and reliability remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we introduce ACEGEN, a comprehensive and streamlined toolkit tailored for generative drug design, built using TorchRL, a modern decision-making library …
agents arxiv cs.ai cs.lg discovery drug discovery generative q-bio.bm reinforcement reinforcement learning type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US